Skip to content

Sarcopenia Measured by Ultrasound in Hospitalized Older Adults

SARCOPENIA MEASURED BY ULTRASOUND IN HOSPITALIZED OLDER ADULTS (ECOSARC Study).

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05113758
Acronym
ECOSARC
Enrollment
161
Registered
2021-11-09
Start date
2019-05-28
Completion date
2022-06-30
Last updated
2023-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia

Keywords

sarcopenia, ultrasound, aged, hospitalized

Brief summary

Observational prospective study in older adults admitted to an Acute Geriatric Unit, in which sarcopenia will be evaluated by ultrasound in the anterior rectus femoris muscle.

Detailed description

The main objective of the study is to estimate, by means of portable ultrasound, parameters of muscle quantity and quality (anterior rectus femoris muscle area, width and echostructure ) in older adults hospitalized in Acute Geriatric Units for medical reasons.

Interventions

DIAGNOSTIC_TESTmuscle ultrasound

All participants will undergo a muscle ultrasound on admission and at discharge

Sponsors

Hospital Universitario Getafe
CollaboratorOTHER
Hospital Infanta Sofia
CollaboratorOTHER
Hospital Universitario Infanta Leonor
CollaboratorOTHER
Hospital Universitario La Paz
CollaboratorOTHER
Puerta de Hierro University Hospital
CollaboratorOTHER
Hospital Virgen del Valle de Toledo
CollaboratorUNKNOWN
Pedro Abizanda
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
69 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients over 69 years of age. * Hospitalization for a medical cause in Acute Geriatric Units. * Holden's Functional Ambulation Classification Scale at level 1 or higher. * Informed consent signed by the patient or legal representative.

Exclusion criteria

* Terminal condition or life expectancy of less than 6 months. * Impossibility or refusal to undergo muscle ultrasound. * Refusal for follow-up * Severe dementia stage Global Deteriorating Scale: 7 * Impossibility in the opinion of the investigators to complete the necessary data for the study.

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of sarcopenia on admission72 hoursPrevalence of sarcopenia on admission. A prevalent case of sarcopenia will be considered if a patient fulfills the EWGSOP2 at admission
Incidence of sarcopenia between admission and discharge15 daysAn incident case of sarcopenia will be considered if a patient not fulfilling EWGSOP2 diagnostic criteria on admission, will meet diagnostic criteria at discharge of sarcopenia at discharge (diagnosis will be considered as a dichotomous variable -yes/no-).
Muscle mass (the anterior rectus femoris muscle)15 daysThe evolution of muscle mass between admission and discharge will be assessed by ultrasound

Secondary

MeasureTime frameDescription
ADL (Activities of Daily Living) questionnaire3 monthsthe ADL questionnaire will also be performed on admission, at discharge, and at 3 months.
SPPB score (SHORT PHYSICAL PERFORMANCE BATTERY score)15 daysShort Physical Performance Battery (SPPB): score range 0-12, higher score means a better outcome
Mortality3 monthsMortality will be measured with vital status at 3 months.
Minimal nutritional assessment (MNA-SF) score72 hoursThe mini-nutritional assessment - short form is a simple, non - invasive and validated scale for the detection of malnutrition in older adults. It takes into account the patient's loss of appetite, weight loss, motor skills, recent health status, neuropsychological disorders. The maximum score of the MNA-SF is 14: Greater than or equal to 11: normal nutritional status. Between 8 and 11: risk of malnutrition. Less than 8: malnutrition.
Readmission(s) after index hospitalization3 monthsReadmission(s) after index hospitalization, Dichotomous outcome (yes/no)
Emergency department (ED) visit(s)3 monthsED visit(s) after index hospitalization, Dichotomous outcome (yes/no)
Length of stay, days15 daysDay of admission to day of discharge
Hand grip strength15 daysUsing a hand-held dynamometer
4-meter walking speed test15 daysThe evolution of the value of the 4-meter walking speed test between admission and discharge will be assessed.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026